Fertility clinics said to lack regulation
By United Press International,
United Press International [cites Marcy Darnovsky]
| 03. 02. 2009
The birth of octuplets in California calls attention to a lack of regulation in the field of assisted reproduction, some experts said.
Although the doctor who supervised in vitro fertilization on the 33-year-old woman who gave birth to octuplets in January is regarded by many in the field as having violated professional norms, U.S. health records indicate a large majority of fertility clinics disregarded implant guidelines in 2006, the Oakland (Calif.) Tribune reported Sunday.
Citing data from the U.S. Centers for Disease Control and Prevention, the newspaper said 80 percent of U.S. fertility clinics in 2006 -- the most recent year for which records are available -- did not follow embryo implant guidelines set in 1999 by the American Society for Reproductive Medicine. The organization advises implanting no more than two embryos in women younger than 35, the report said.
"Assisted reproduction is a multibillion-dollar business," Marcy Darnovsky of the Center for Genetics and Society in Oakland said. "Like other commercial enterprises, it needs rules."
ASRM spokesman Sean Tipton told the newspaper exceptions to the guidelines are permitted, and the...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...